Further evidence for the benefits of secukinumab in AS patients
medwireNews,
04-01-2018 | Rheumatology | News | Article medwireNews: Results of the phase III MEASURE 3 trial provide additional support for…
04-01-2018 | Rheumatology | News | Article medwireNews: Results of the phase III MEASURE 3 trial provide additional support for…
Action Points Patients with ankylosing spondylitis have shown rapid and sustained responses to secukinumab (Cosentyx) in a…